The Native Antigen Company is part of LGC Clinical Diagnostics - Learn More

0 Items
Select Page

Listeria

Listeria monocytogenes is the causative agent of a rare but severe and life threatening food-borne disease known as listeriosis. In most people, Listeria monocytogenes infection may cause a self-limiting febrile illness. In pregnant women, newborn babies and immunocompromised people, the disease can cause severe illness or even death. Although the number of annual reported cases of Listeriosis are relatively small, the high risk of mortality in these individuals is of significant global health concern.

To support Listeria monocytogenes research, we have developed antibodies that work together as a matched pair in ELISA assays, and are suitable for immunoassay research and development.

Listeria Background

Listeria monocytogenes is the causative agent of a severe and life-threatening food-borne disease known as listeriosis.

In nature, L. monocytogenes (Lm) is ubiquitous in soil, water, animal waste and decaying plants, where it acts as a saprophyte. Transmission of Lm to humans can occur via a diverse range of food types including pre-cooked contaminated meat, unpasteurised dairy products, soft cheese, vegetables, fruit and undercooked ready-to-eat food products.

In healthy adults, Lm infection may be asymptomatic or cause a self -limiting flu-like illness with vomiting and diarrhoea. However, in the elderly, newborn infants and immunocompromised individuals, invasive L.monocytogenes infection can occur leading to life-threatening diseases such as meningitis and septicaemia. In pregnant women, infection of the foetus in utero can cause spontaneous abortion (CDC).

Although the number of annual reported cases of Listeriosis are relatively small, most patients with listeriosis require hospitalisation and the risk of death is high in these cases. In addition, Lm infection is the reported to be the third leading cause of foodborne death and is therefore a global health concern.

References

Centers for Disease Control and Prevention: Listeria (Listeriosis)

Listeria Antigens

The Native Antigen Company is please to supply a native Listeria antigen as part of its BacTrace range of matching antigens and antibodies.

Listeria Antibodies

The Native Antigen Company supply monoclonal antibodies designed for Listeria monocytogenes immunoassay research and development. Our monoclonal antibodies MAB12259 (clone LZF7) and MAB12260 (clone LZH1) work together as a capture- detection antibody pair in sandwich immunoassays.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Monkeypox; 3 months on

It has been 3 months since a new, unusually widespread outbreak of Monkeypox was first identified. What was normally a virus confined to limited infections in the West African continent is becoming a global health concern.   What have we learned about this virus...

COVID-19 Underlines the Need for Universal Vaccines

This article was originally published on Clinical Lab Manager. In recent history, humanity has witnessed numerous emerging viral diseases, including the SARS, MERS, and SARS-2 coronaviruses, as well as HIV, Zika, Ebola, and H1N1 and H3N2 influenza. None have tested...

Tick-Borne Diseases: The Need for Integrated Approaches to Human-Animal Diagnosis

This article has been published in Volume 8, Issue 3 of International Animal Health Journal. Ticks are responsible for a diverse group of neglected, and rapidly expanding diseases, affecting humans, companion animals and livestock. A growing understanding of tick-host...

The Continued Challenges of Flavivirus Serology

This article was originally published on the Science Advisory Board. Flaviviruses are a genus of positive-sense RNA viruses, largely transmitted by mosquito and tick vectors that cause infections, including yellow fever, dengue, the Zika virus, West Nile virus,...

The Role of Serology in Tracking COVID-19 Mutations

This article was originally published on Clinical Lab Products. As SARS-CoV-2 began its global proliferation in early 2020, scientists hastened to investigate its biology, develop diagnostic tests, and design candidate vaccines, marking one of the most...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

11 + 6 =